前列腺癌治疗后平均15年生活质量的患者报告结局:基于扩展前列腺癌指数(EPIC)的评估
本研究对接受开放根治性前列腺切除术(RP)、三维适形放疗(3D CRT)或125I低剂量率近距离放疗(BT)的前列腺癌患者,在中位15.8年随访时采用EPIC量表评估生活质量。结果显示泌尿刺激和肠道领域在3D CRT或BT后较RP持续恶化,RP后尿失禁有更差趋势但无统计学差异。作者指出所评估的治疗方式可能不反映现代技术。
要点
- 中位15.8年时,3D CRT或BT后泌尿刺激和肠道领域较RP持续恶化。
- RP后尿失禁有更差趋势,但各放疗方式间无统计学差异。
- 所评估的开放RP、无影像引导3D CRT和无MRI引导BT可能不反映现代技术。
核心结论
- 作为EPIC患者报告结局中最长随访的数据,这些数据独特地揭示了治疗后2至15年的时间趋势。
- 然而,开放RP、无影像引导或调强适形的3D CRT、以及无周边加载或MRI引导的BT等治疗方式可能不反映现代技术。
研究设计与样本
- 对既往报告过治疗后平均2年和6年生活质量的前列腺癌男性进行更新分析,治疗方式包括开放根治性前列腺切除术(RP)、三维适形放疗(3D CRT)或125I低剂量率近距离放疗(BT)。
- 采用EPIC量表各领域评分,在中位15.8年随访时基于平均EPIC汇总领域评分以ANOVA及经年龄调整的成对事后比较评估差异。
- 报告当前调查与首次横断面相比的患者差异,以各治疗组在中位2.2年、6.0年和15.8年时的汇总评分中位变化表示。
主要发现
- 仍在世的男性中,BT应答率为52%,3D CRT为60%,RP为62%,在中位15.8年随访时各相应方式分别获得30、41和330份生活质量问卷用于评估。
- RP、3D CRT和BT后男性平均年龄分别为75.3、83.6和79.3岁。
- 在中位15.8年时,EPIC领域 largely 持续存在差异,生活质量自中间时间点无实质性演变。
- 与RP相比,3D CRT或BT后泌尿刺激和肠道领域持续恶化。
- RP后尿失禁有更差趋势,但各放疗选择间无统计学差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 所评估的治疗方式包括开放RP、无影像引导或调强适形的3D CRT、以及无周边加载或MRI引导的BT,可能不反映现代技术。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE/PURPOSE: Previously patient reported quality of life (QOL) was reported in men with prostate cancer a mean 2 and 6 years post treatment with open radical prostatectomy (RP), 3D conformal radiation therapy (3D CRT), or 125I low dose rate (LDR) brachytherapy (BT). Herein we update the results 15 years post-treatment QOL. MATERIALS/METHODS: The Expanded Prostate Cancer Index (EPIC) domains were scored with differences evaluated at a median 15.8 years follow up based upon mean EPIC summary domains by ANOVA with pairwise post-hoc comparisons adjusted for age. Patient differences of current survey from first cross-section are reported as median change in summary score for each treatment group at median of 2.2 and 6.0, and 15.8 years. RESULTS: Among men still alive response rate was 52% in BT, 60% in 3D CRT, and 62% in RP resulting in 30, 41, and 330 QOL questionnaires to evaluate for each corresponding modality at median follow up of 15.8 years. Men were a mean 75.3, 83.6, and 79.3 years of age after RP, 3DCRT, and BT, respectively.At a median of 15.8 years, there were largely persistent differences in EPIC domains without substantial evolution in QoL from middle time points. Persistent worsening in urinary irritative and bowel domain with 3DRT or BT compared to RP. Trend towards worse urinary incontinence with RP were noted without statistical differences within radiotherapy options. CONCLUSION: As the EPIC patient reported outcomes with the longest follow-up, these data uniquely reveal temporal trends from 2 to 15 years post treatment. However, the treatment modalities of open RP, 3D CRT without image guidance or intensity modulation, and BT without peripheral loading or MRI guidance may not reflect modern techniques.
引用
- Seymour ZA, Daignault-Newton S, McLaughlin PW, et al. Patient reported outcomes for quality of life (QOL) by Expanded Prostate Cancer Index (EPIC) on average 15 years post treatment. Clin Transl Radiat Oncol. 2022. PMID: 35813938. doi:10.1016/j.ctro.2022.05.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。